Rader JS - Search Results

1

Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfaction.

Swisher EM, Babb S, Whelan A, Mutch DG, Rader JS. Swisher EM, et al. Among authors: rader js. J Reprod Med. 2001 Feb;46(2):87-94. J Reprod Med. 2001. PMID: 11255821

2

Relationship of ovarian neoplasms and body mass index.

Wright JD, Powell MA, Mutch DG, Rader JS, Gibb RK, Gao F, Herzog TJ. Wright JD, et al. Among authors: rader js. J Reprod Med. 2005 Aug;50(8):595-602. J Reprod Med. 2005. PMID: 16220765

3

Qualitative Evaluation of Medical Information Processing Needs of 60 Women Choosing Ovarian Cancer Surveillance or Prophylactic Oophorectomy.

Babb SA, Swisher EM, Heller HN, Whelan AJ, Mutch DG, Herzog TJ, Rader JS. Babb SA, et al. Among authors: rader js. J Genet Couns. 2002 Apr;11(2):81-96. doi: 10.1023/A:1014571420844. J Genet Couns. 2002. PMID: 26141655

4

Effects of cancer treatment on ovarian function.

Stroud JS, Mutch D, Rader J, Powell M, Thaker PH, Grigsby PW. Stroud JS, et al. Among authors: rader j. Fertil Steril. 2009 Aug;92(2):417-27. doi: 10.1016/j.fertnstert.2008.07.1714. Epub 2008 Sep 6. Fertil Steril. 2009. PMID: 18774559 Free article. Review.

5

Use of complementary and alternative medicine among women with gynecologic cancers.

Swisher EM, Cohn DE, Goff BA, Parham J, Herzog TJ, Rader JS, Mutch DG. Swisher EM, et al. Among authors: rader js. Gynecol Oncol. 2002 Mar;84(3):363-7. doi: 10.1006/gyno.2001.6515. Gynecol Oncol. 2002. PMID: 11855870

6

"Surgical Apgar Score" predicts postoperative complications after cytoreduction for advanced ovarian cancer.

Zighelboim I, Kizer N, Taylor NP, Case AS, Gao F, Thaker PH, Rader JS, Massad LS, Mutch DG, Powell MA. Zighelboim I, et al. Among authors: rader js. Gynecol Oncol. 2010 Mar;116(3):370-3. doi: 10.1016/j.ygyno.2009.11.031. Epub 2009 Dec 16. Gynecol Oncol. 2010. PMID: 20015540

7

A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer.

Wright JD, Secord AA, Numnum TM, Rocconi RP, Powell MA, Berchuck A, Alvarez RD, Gibb RK, Trinkaus K, Rader JS, Mutch DG. Wright JD, et al. Among authors: rader js. Int J Gynecol Cancer. 2008 May-Jun;18(3):400-6. doi: 10.1111/j.1525-1438.2007.01027.x. Epub 2007 Jul 21. Int J Gynecol Cancer. 2008. PMID: 17645510

8

Topotecan in platinum- and paclitaxel-resistant ovarian cancer.

Swisher EM, Mutch DG, Rader JS, Elbendary A, Herzog TJ. Swisher EM, et al. Among authors: rader js. Gynecol Oncol. 1997 Sep;66(3):480-6. doi: 10.1006/gyno.1997.4787. Gynecol Oncol. 1997. PMID: 9299264 Clinical Trial.

9

Cancer among first-degree relatives of probands with invasive and borderline ovarian cancer.

Rader JS, Neuman RJ, Brady J, Babb S, Temple S, Kost E, Mutch DG, Herzog TJ. Rader JS, et al. Obstet Gynecol. 1998 Oct;92(4 Pt 1):589-95. doi: 10.1016/s0029-7844(98)00275-0. Obstet Gynecol. 1998. PMID: 9764634

10

Atypical clustering of gynecologic malignancies: A family study including molecular analysis of candidate genes.

Cohn DE, Babb S, Whelan AJ, Mutch DG, Herzog TJ, Rader JS, Elbendary A, Goodfellow PJ. Cohn DE, et al. Among authors: rader js. Gynecol Oncol. 2000 Apr;77(1):18-25. doi: 10.1006/gyno.1999.5709. Gynecol Oncol. 2000. PMID: 10739686

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

256 results

Search Page